Market Overview

PTC Therapeutics (NASDAQ: PTCT)

59.30 +0.94 (1.61%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/23/20Cantor FitzgeraldMaintainsOverweight81.0
11/13/19Credit SuisseMaintainsOutperform58.0
11/12/19SunTrust Robinson HumphreyInitiates Coverage OnBuy78.0
10/30/19CitigroupMaintainsBuy55.0
5/13/19Bank of AmericaUpgradesBuy49.0
4/11/19BernsteinInitiates Coverage OnOutperform48.0
11/12/18Cantor FitzgeraldMaintainsOverweight61.0
11/06/18RBC CapitalMaintainsOutperform46.0
11/06/18BarclaysMaintainsEqual-Weight40.0
10/01/18Cantor FitzgeraldInitiates Coverage OnOverweight66.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter